We are live on ! Find out more
RA

Royce & Associates Portfolio holdings

AUM $12.4B
1-Year Est. Return 64.17%
This Fund
S&P 500
This Quarter Est. Return
+1.43%
1 Year Est. Return
+64.17%
3 Year Est. Return
+130.04%
5 Year Est. Return
+162.55%
10 Year Est. Return
+785.5%
AUM
$10.8B
AUM Growth
-$261M
Cap. Flow
-$202M
Cap. Flow %
-1.87%
Top 10 Hldgs %
9.55%
Holding
1,226
New
73
Increased
457
Reduced
388
Closed
76

Top Buys

Rank Stock Value
1
VIRT icon
Virtu Financial
VIRT
+$33.4M
2
MLAB icon
Mesa Laboratories
MLAB
+$27.4M
3
TNC icon
Tennant Co
TNC
+$19.8M
4
KWR icon
Quaker Houghton
KWR
+$18.2M
5
HLI icon
Houlihan Lokey
HLI
+$17.9M

Sector Composition

Rank Sector Weight
1 Industrials 28.27%
2 Technology 17.79%
3 Financials 14.2%
4 Consumer Discretionary 12.75%
5 Materials 8.44%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FIZZ icon
1026
National Beverage
FIZZ
$2.94B
$64K ﹤0.01%
2,866
+1,180
+70% +$25.5K
IDCC icon
1027
InterDigital
IDCC
$8.41B
$64K ﹤0.01%
1,213
+547
+82% +$30.9K
NBR icon
1028
Nabors Industries
NBR
$1.36B
$64K ﹤0.01%
680
ZAGG
1029
DELISTED
ZAGG Inc Common Stock (Delaware)
ZAGG
$62K ﹤0.01%
9,900
-5,000
-34% -$32.3K
OTTR icon
1030
Otter Tail
OTTR
$3.7B
$61K ﹤0.01%
1,143
+404
+55% +$21.1K
OCSL icon
1031
Oaktree Specialty Lending
OCSL
$1.09B
$60K ﹤0.01%
3,863
+1,450
+60% +$22.8K
WW
1032
DELISTED
WW International
WW
$60K ﹤0.01%
1,590
-73
-4% -$2.06K
NHC icon
1033
National Healthcare
NHC
$3.55B
$59K ﹤0.01%
723
+251
+53% +$20.8K
AMR icon
1034
Alpha Metallurgical Resources
AMR
$2.39B
$58K ﹤0.01%
2,074
+1,246
+150% +$43.3K
CARS icon
1035
Cars.com
CARS
$632M
$58K ﹤0.01%
+6,484
New +$87.5K
LGND icon
1036
Ligand Pharmaceuticals
LGND
$5.52B
$58K ﹤0.01%
927
+414
+81% +$26K
AKS
1037
DELISTED
AK Steel Holding Corp
AKS
$58K ﹤0.01%
25,442
-510,492
-95% -$1.23M
HEES
1038
DELISTED
H&E Equipment Services
HEES
$57K ﹤0.01%
1,976
+712
+56% +$19.3K
JACK icon
1039
Jack in the Box
JACK
$261M
$57K ﹤0.01%
+622
New +$51.7K
SYNA icon
1040
Synaptics
SYNA
$3.81B
$57K ﹤0.01%
+1,420
New +$47.9K
SYKE
1041
DELISTED
SYKES Enterprises Inc
SYKE
$56K ﹤0.01%
1,816
+474
+35% +$13.7K
MMSI icon
1042
Merit Medical Systems
MMSI
$5.15B
$54K ﹤0.01%
1,788
-249,266
-99% -$10.1M
PINC
1043
DELISTED
Premier
PINC
$54K ﹤0.01%
1,871
+688
+58% +$25.6K
NC icon
1044
NACCO Industries
NC
$292M
$53K ﹤0.01%
837
+286
+52% +$14.9K
PKE icon
1045
Park Aerospace
PKE
$672M
$53K ﹤0.01%
+3,040
New +$53K
LRN icon
1046
Stride
LRN
$3.47B
$51K ﹤0.01%
1,935
+859
+80% +$24.7K
THFF icon
1047
First Financial Corp
THFF
$929M
$51K ﹤0.01%
1,164
+375
+48% +$15.6K
ARNA
1048
DELISTED
Arena Pharmaceuticals Inc
ARNA
$51K ﹤0.01%
1,116
+455
+69% +$25.6K
UNT
1049
DELISTED
UNIT Corporation
UNT
$51K ﹤0.01%
15,000
-40,713
-73% -$200K
WTTR icon
1050
Select Water Solutions
WTTR
$2.67B
$50K ﹤0.01%
5,762
+3,084
+115% +$28.3K

Similar funds

Royce & Associates's Q3 2019 Portfolio in Review

As of Q3 2019, Royce & Associates held 1,226 positions worth $10.8B, down 2.4% from $11.1B the previous quarter. Its ten largest holdings account for 9.6% of the portfolio.

Royce & Associates's Q3 2019 filing shows 73 new, 457 increased, 388 reduced and 76 closed positions. Its largest new stake was Upbound Group: 521,616 shares worth $13.5M. The largest sale was John B. Sanfilippo & Son, an estimated $73.8M.

By sector, the portfolio is most concentrated in Industrials at 28% of assets, down from 29% a quarter earlier, followed by Technology and Financials.

  • Royce & Associates's largest Q3 2019 buy was Upbound Group: 521,616 shares worth $13.5M.
  • Royce & Associates added most to Virtu Financial in Q3 2019, an estimated $33.4M increase.
  • Royce & Associates's biggest Q3 2019 reduction was John B. Sanfilippo & Son, cutting an estimated $73.8M.
  • Royce & Associates fully exited Cambrex Corporation in Q3 2019, selling an estimated $14.7M.
  • Royce & Associates's ten largest holdings make up 9.6% of its $10.8B portfolio in Q3 2019.
  • Royce & Associates opened 73 new positions and closed 76 in Q3 2019.
  • Royce & Associates's portfolio value fell 2.4% quarter-over-quarter to $10.8B.

Based on Royce & Associates's 13F filing for Q3 2019, filed 13 Nov 2019.